John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$251M |
| 2 |
Eli Lilly
LLY
|
+$246M |
| 3 |
Cisco
CSCO
|
+$226M |
| 4 |
Chevron
CVX
|
+$224M |
| 5 |
Mastercard
MA
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$262M |
| 2 |
XYZ
Block Inc
XYZ
|
+$236M |
| 3 |
Target
TGT
|
+$228M |
| 4 |
TJX Companies
TJX
|
+$222M |
| 5 |
Roku
ROKU
|
+$221M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 15.24% |
| 3 | Consumer Discretionary | 8.56% |
| 4 | Financials | 8.41% |
| 5 | Industrials | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
CALL
Schrodinger
SDGR
$1.46B
| $766K | ﹤0.01% |
14,000
+11,000
| +367% | +$704K |
|
|
KLR
2852
DELISTED
Kaleyra, Inc.
KLR
| $766K | ﹤0.01% |
19,876
+14,781
| +290% | +$582K |
|
2853
Custom Truck One Source
CTOS
$2.18B
| $764K | ﹤0.01% |
81,900
+26,744
| +48% | +$225K |
|
2854
PUT
Kroger
KR
$35.9B
| $764K | ﹤0.01% |
18,900
-51,500
| -73% | -$2.16M |
|
2855
PUT
Tandem Diabetes Care
TNDM
$1.49B
| $764K | ﹤0.01% |
6,400
-12,600
| -66% | -$1.39M |
|
2856
CorVel
CRVL
$3.55B
| $762K | ﹤0.01% |
12,270
-72,276
| -85% | -$3.77M |
|
2857
PUT
M&T Bank
MTB
$34.9B
| $762K | ﹤0.01% |
5,100
+1,100
| +28% | +$152K |
|
2858
CALL
Elastic
ESTC
$8.23B
| $760K | ﹤0.01% |
5,100
+2,100
| +70% | +$323K |
|
2859
Universal Logistics Holdings
ULH
$504M
| $760K | ﹤0.01% |
37,858
+7,023
| +23% | +$152K |
|
2860
PUT
Globant
GLOB
$1.67B
| $759K | ﹤0.01% |
2,700
-600
| -18% | -$165K |
|
2861
Allegro MicroSystems
ALGM
$6.87B
| $757K | ﹤0.01% |
23,700
+12,300
| +108% | +$362K |
|
2862
CALL
Bristol-Myers Squibb
BMY
$138B
| $757K | ﹤0.01% |
12,800
-68,200
| -84% | -$4.49M |
|
|
VISN
2863
CALL
Vistance Networks Inc
VISN
$2.55B
| $757K | ﹤0.01% |
+55,700
| New | +$957K |
|
2864
CALL
Paylocity
PCTY
$8.07B
| $757K | ﹤0.01% |
2,700
-1,600
| -37% | -$384K |
|
|
HIBB
2865
PUT
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $757K | ﹤0.01% |
10,700
+7,800
| +269% | +$681K |
|
|
MPT
2866
PUT
Medical Properties Trust
MPT
$2.44B
| $755K | ﹤0.01% |
37,600
+16,800
| +81% | +$344K |
|
|
SQSP
2867
DELISTED
Squarespace, Inc.
SQSP
| $755K | ﹤0.01% |
19,527
-53,820
| -73% | -$2.6M |
|
|
TGI
2868
DELISTED
Triumph Group
TGI
| $753K | ﹤0.01% |
40,445
-107,794
| -73% | -$2.01M |
|
2869
PUT
Everest Group
EG
$14.6B
| $752K | ﹤0.01% |
3,000
-2,000
| -40% | -$513K |
|
2870
Ligand Pharmaceuticals
LGND
$5.73B
| $752K | ﹤0.01% |
8,656
| – | – |
|
2871
PUT
National Beverage
FIZZ
$3.09B
| $751K | ﹤0.01% |
14,300
-14,400
| -50% | -$670K |
|
2872
Univest Financial
UVSP
$1.15B
| $750K | ﹤0.01% |
27,394
+9,139
| +50% | +$245K |
|
2873
Evertec
EVTC
$1.78B
| $749K | ﹤0.01% |
16,381
-65,939
| -80% | -$2.97M |
|
2874
CALL
Bio-Rad Laboratories Class A
BIO
$10.4B
| $746K | ﹤0.01% |
1,000
| – | – |
|
2875
CALL
Apollo Global Management
APO
$78.9B
| $745K | ﹤0.01% |
+12,100
| New | +$727K |
|
Similar funds
John Overdeck's Q3 2021 Portfolio in Review
As of Q3 2021, John Overdeck held 4,966 positions worth $44.7B, up 1.5% from $44.1B the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
John Overdeck deployed $1.71B of net new capital in Q3 2021, opening 996 new positions and adding to 1,597 existing holdings. Its largest new stake was PayPal: 884,227 shares worth $230M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Block Inc, an estimated $236M trimmed.
- John Overdeck's largest Q3 2021 buy was PayPal: 884,227 shares worth $230M.
- John Overdeck added most to Cisco in Q3 2021, an estimated $226M increase.
- John Overdeck's biggest Q3 2021 reduction was Block Inc, cutting an estimated $236M.
- John Overdeck fully exited Pfizer in Q3 2021, selling an estimated $262M.
- John Overdeck's ten largest holdings make up 5.2% of its $44.7B portfolio in Q3 2021.
- John Overdeck opened 996 new positions and closed 790 in Q3 2021.
- John Overdeck's portfolio value rose 1.5% quarter-over-quarter to $44.7B.
Based on Two Sigma Investments's 13F filing for Q3 2021, filed 15 Nov 2021.